RJR-2429

N/A

Report date: 2023/10/16 09:01:14
NME

Base Information

Drug NameRJR-2429
Drug Alias NameRJR-2429
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic acetylcholine receptor alpha-4/beta-2 antagonistsNeuronal acetylcholine receptor protein alpha-7 subunit modulators
TargetsNicotinic acetylcholine receptor alpha-4/beta-2Neuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A